Physician profile
Antonio J Gayoso
NPI 1568435832
$65,292.92
in general payments reported to CMS, 2019-2025
10 companies · $5,715 in 2025
The $5,715 reported for 2025 was more than what 93% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,066 · 2020: $464 · 2021: $7,512 · 2022: $27K · 2023: $7,828 · 2024: $11K · 2025: $5,715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $3,411 · Consulting Fee: $1,814 · Travel and Lodging: $812 · Gift: $87.00 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,569.42 |
| Food and Beverage | $3,410.56 |
| Consulting Fee | $1,814.25 |
| Travel and Lodging | $811.64 |
| Gift | $87.00 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $40,127.21 | 2019-2022 | |
| Abbvie INC. | $20,894.19 | 2023-2025 | |
| Motiva USA, LLC | $3,712.23 | 2024-2025 | |
| Tepha INC | $182.29 | 2020 | |
| Merz North America, INC. | $134.59 | 2021-2023 | Xeomin |
| Baxter Healthcare | $120.68 | 2019 | |
| Revance Therapeutics, INC. | $57.75 | 2025 | Daxxify |
| Galderma Laboratories, L.P. | $26.56 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.52 | 2019 | |
| Mesh Suture INC | $12.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Gayoso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.